Atlas Trials

Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Clinical trial NCT03963895 · COMPLETED

Trial details

NCT number
NCT03963895
Sponsor
Aronora, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
End Stage Renal DiseaseThrombosis
Start date
2019-07-03
Primary completion
2020-12-29
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.